Chemotherapy for Breast Cancer

Chemotherapy treatment uses medicine to weaken and destroy cancer cells in the body, including cells at the original cancer site and any cancer cells that may have spread to another part of the body. There are quite a few chemotherapy medicines. In many cases, a combination of two or more medicines will be used as chemotherapy treatment for breast cancer. Chemotherapy is used to treat early-stage invasive breast cancer to get rid of any cancer cells that may be left behind after surgery and to reduce the risk of the cancer coming back; advanced-stage breast cancer to destroy or damage the cancer cells as much as possible. Chemotherapy medicines prevent cancer cells from growing and spreading by destroying the cells or stopping them from dividing.

Adjuvant Therapy for breast cancer is any treatment given after primary therapy to increase the chance of long-term disease-free survival. Primary therapy is the main treatment used to reduce or eliminate the cancer. Not all women with breast cancer need adjuvant therapy. Patients at higher risk of cancer recurrence are more likely to need adjuvant therapy. Doctors look at both prognostic and predictive factors to decide which patients might benefit from adjuvant treatments. Prognostic factors help doctors estimate how likely a tumor is to recur. Predictive factors help doctors estimate how likely cancer cells are to respond to a particular treatment. Even in early-stage breast cancer, cells may break away from the primary tumor and spread to other parts of the body (metastasize). Therefore, doctors give adjuvant therapy to kill any cancer cells that may have spread, even if they cannot be detected by imaging or laboratory tests. Studies have shown that adjuvant therapy for breast cancer may increase the chance of long-term survival by preventing a recurrence.

Neoadjuvant Therapy is treatment given before primary therapy. A woman may receive neoadjuvant chemotherapy for breast cancer to shrink a tumor that is inoperable in its current state, so it can be surgically removed. A woman whose tumor can be removed by mastectomy may instead receive neoadjuvant therapy to shrink the tumor enough to allow breast-conserving surgery. Neoadjuvant chemotherapy is given in the same manner as adjuvant chemotherapy. If a tumor does not respond (shrink) or continues to grow during neoadjuvant chemotherapy, the doctor may stop treatment and try another type of chemotherapy or perform surgery instead, depending on the stage of the cancer. Clinical trials are examining whether hormonal therapy or trastuzumab is effective when given before surgery.

  • Neoadjuvant Chemotherapy
  • Adjuvant Chemotherapy
  • Dose-dense Chemotherapy
  • Combinational Chemotherapy
  • Breast Cancer in Young Women and in Pregnancy
  • HER-2 Positive Breast Cancer
  • Breast cancer, Psychosis and Schizophrenia

Related Conference of Chemotherapy for Breast Cancer

July 20-22, 2017

4th World Congress on Midwifery and Women’s Health

Melbourne, Australia
July 24-26, 2017

25th World Congress on Nursing Care

Melbourne, Australia
August 21-22, 2017

4th Annual Congress & Medicare Expo on Primary Healthcare

San Francisco, California, USA
August 28-30, 2017

29th World Neonatal Nursing and Maternal Healthcare Congress

Philadelphia, Pennsylvania, USA
Aug 28-30, 2017

2nd World Congress on Midwifery and Women’s Health

Philadelphia, Pennsylvania, USA
August 31- September 02, 2017

26th World Nursing Education Conference

Prague, Czech Republic
September 04-06, 2017, Edinburgh, Scotland

30th World Congress on Advanced Nursing Practice

September 04-05, 2017

28th International Conference on Pediatric Nursing and Healthcare

Edinburgh, Scotland
September 11-13, 2017

28th International Conference on Family Nursing and Healthcare

San Antonio,Texas, USA
September 25-26, 2017

35th Global Nursing Care and Education Conference

Atlanta, Georgia ,USA
September 28-29, 2017

23rd World Nurse Practitioner Conference

Dubai, UAE
October 02-04, 2017

4th International Conference on Gynecology & Obstetrics


TRYP BARCELONA AEROPUERTO, Barcelona, Spain
(10Plenary Forums - 1Event)
October 16-18, 2017,

6th World Congress on Breast Cancer & Therapy

Hotel- Crowne Plaza San Francisco Airport, San Francisco, CA
October 20-21, 2017

37th Asia-Pacific Nursing and Medicare Summit

Osaka, Japan
October 23-25, 2017

33rd Nursing and Healthcare
Congress

Toronto, Canada
October 26-28, 2017

32nd Euro Nursing & Medicare
Summit

Paris, France
November 08-09, 2017

34thInternational Nurse Education & Nurse Specialist Conference

New Orleans, Louisiana, USA
Dec 06-07, 2017

46th Global Nursing and Healthcare Conference

Sao Paulo, Brazil
March 01-03, 2018

47th Global Nursing & Healthcare Conference

London, UK
March 21-23, 2018

20th Global Nursing Education Conference

New York, USA
May 10-11, 2018

7th World Congress on Breast Cancer

Frankfurt, Germany
14th - 15th June, 2018

48th World Congress on Advanced Nursing Research

Dublin, Ireland
July 16-17, 2018

50th World Congress on Men in Nursing

Rome, Italy
July 16-17, 2018

7th World Congress on Breast Cancer

Melbourne, Australia
July 16-18, 2018

21st World Nursing Education Conference

Melbourne, Australia
August 29-31, 2018

17th World Congress on Clinical Nursing and Practice

Zurich, Swtizerland

Chemotherapy for Breast Cancer Conference Speakers

Recommended Sessions

Related Journals

Are you interested in